Topline data were announced from a phase 3 trial evaluating orforglipron in adults with obesity or overweight with weight-related comorbidities.

Telecommunications giant Optus faces potential civil penalties of up to $20.9 trillion after the Office of the Australian ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

Prosus and JET have Obtained all Regulatory Clearances to close the Offer for Just Eat Takeaway.com Prosus N.V. (Incorporated in the Netherlands) (Legal Entity Identifier: 635400Z5LQ5F9OLVT688) AEX ...

The Dispatch is a new digital media company providing engaged citizens with fact-based reporting and commentary, informed by conservative principles. Sign up for free.